000			02320 a2200685 4500
005			20250515035536.0
264		0	_c20060915
008			200609s 0 0 eng d
022			_a0007-0920
024	7		_a10.1038/sj.bjc.6603271 _2doi
040			_aNLM _beng _cNLM
100	1		_aAtzpodien, J
245	0	0	_aInterleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). _h[electronic resource]
260			_bBritish journal of cancer _cAug 2006
300			_a463-9 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aCapecitabine
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aGermany
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aInterleukin-2 _xadministration & dosage
650	0	4	_aIsotretinoin _xadministration & dosage
650	0	4	_aKidney Neoplasms _xdrug therapy
650	0	4	_aLung Neoplasms _xsecondary
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRecombinant Proteins
650	0	4	_aSurvival Analysis
700	1		_aKirchner, H
700	1		_aRebmann, U
700	1		_aSoder, M
700	1		_aGertenbach, U
700	1		_aSiebels, M
700	1		_aRoigas, J
700	1		_aRaschke, R
700	1		_aSalm, S
700	1		_aSchwindl, B
700	1		_aMüller, S C
700	1		_aHauser, S
700	1		_aLeiber, C
700	1		_aHuland, E
700	1		_aHeinzer, H
700	1		_aSiemer, S
700	1		_aMetzner, B
700	1		_aHeynemann, H
700	1		_aFornara, P
700	1		_aReitz, M
773	0		_tBritish journal of cancer _gvol. 95 _gno. 4 _gp. 463-9
856	4	0	_uhttps://doi.org/10.1038/sj.bjc.6603271 _zAvailable from publisher's website
999			_c16496417 _d16496417